USA Priya Kishnani, Director of the Division of Medical Genetics at Duke University School of Medicine, discusses how multidisciplinary care, global collaboration, and rapidly advancing therapeutic technologies are reshaping the rare disease landscape. Drawing on decades of experience across diagnosis, natural history research, and the development of transformative treatments, she outlines…
See our Cookie Privacy Policy Here
